#GSK

As antibiotic resistance continues to increase for uncomplicated UTIs, there is an urgent need for alternative treatment options. Gepotidacin (BLUJEPA), a first-in-class new antibiotic with a novel mechanism of action. It may represent a therapeutic alternative for uncomplicated UTI management. Let us explore this further.